User profiles for Lou Lukas
Lou LukasDirector Palliative Care, Veterans Affairs, NWI Verified email at va.gov Cited by 234 |
Hospital outcomes for a home-based palliative medicine consulting service
Background: There is a growing need for palliative care services located outside of hospitals.
Objective: This study's objective was to evaluate a home-based, nonhospice, palliative …
Objective: This study's objective was to evaluate a home-based, nonhospice, palliative …
[PDF][PDF] An ounce of prevention? Evaluation of the'Put Prevention into Practice'program
BACKGROUND. The'‘Put Prevention into Practice”(PPIP) program was designed to enhance
the capacity of health care providers to deliver clinical preventive services. This study was …
the capacity of health care providers to deliver clinical preventive services. This study was …
Delivering specialized palliative care in the community: A new role for nurse practitioners
…, N Gratz, C Davidson, L Lukas… - Advances in Nursing …, 2011 - journals.lww.com
The rising population of older Americans with advanced illness challenges current care
delivery models. We use the metaphor of advanced illness as a difficult journey and propose a …
delivery models. We use the metaphor of advanced illness as a difficult journey and propose a …
The Phenomenon of Collaboration: A Phenomenologic Study of Collaboration between Family Medicine and Obstetrics and Gynecology Departments at an Academic …
Collaboration is essential to manage complex real world problems. We used phenomenologic
methods to elaborate a description of collaboration between two departments at an …
methods to elaborate a description of collaboration between two departments at an …
Management of patients with Crohn's disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting
The 2020 annual meeting for IOIBD was scheduled to occur in March, but was cancelled
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …
[HTML][HTML] Infliximab reduces endoscopic, but not clinical, recurrence of Crohn's disease after ileocolonic resection
…, M Chevrier, S Plevy, J Popp, FJ Cornillie, M Lukas… - Gastroenterology, 2016 - Elsevier
Background & Aims Most patients with Crohn’s disease (CD) eventually require an intestinal
resection. However, CD frequently recurs after resection. We performed a randomized trial …
resection. However, CD frequently recurs after resection. We performed a randomized trial …
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial
…, JP Gisbert, AG Casbas, E Louis… - The Lancet …, 2022 - thelancet.com
Background A treat-to-target strategy, in which strictly defined treatment targets facilitate
decision making in clinical practice, is advocated as an optimised management approach for …
decision making in clinical practice, is advocated as an optimised management approach for …
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of …
Environmental and lifestyle factors play an important role in the natural history of Crohn's
disease and ulcerative colitis. A group of international experts from the International …
disease and ulcerative colitis. A group of international experts from the International …
[HTML][HTML] Prediction of relapse after anti–tumor necrosis factor cessation in Crohn's disease: individual participant data meta-analysis of 1317 patients from 14 studies
…, T Molnár, E Leo, S Bots, R Downey, M Lukas… - Clinical …, 2022 - Elsevier
Background & Aims Tools for stratification of relapse risk of Crohn’s disease (CD) after anti–tumor
necrosis factor (TNF) therapy cessation are needed. We aimed to validate a previously …
necrosis factor (TNF) therapy cessation are needed. We aimed to validate a previously …
Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic …
KA Klute, L Lukas, S Hwang, Y Gwon, M Krishnan… - Cancer Research, 2024 - AACR
Background: Psychological distress is a common reaction to a cancer diagnosis and its
treatment. Distress impacts quality of life, adherence to treatment, decision making and survival. …
treatment. Distress impacts quality of life, adherence to treatment, decision making and survival. …